Cited by 97Bone fractures and treatmentsBone health and osteoporosis researchBone Tissue Engineering Materials

Drugs and fracture repair

Open access
Aspenberg, Per·2005·Acta Orthopaedica

Abstract

The repair of long bones has not been optimized by Mother Nature. One would think that such a complicated process, leading to replacement of damaged tissue and restoration of function, would be the...

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/17453670510045318

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a review, Per Aspenberg listed drugs that improve fracture healing: growth factors (FGF 1 and 2, TGF-1, GH, BMPs), PTH, selective prostaglandin agonists, statins, and beta blockers.

    “The drugs he listed that improve fracture healing were growth factors (fibroblast growth factors (FGF) 1 and 2, transforming growth factor 1 (TGF-1), growth hormone (GH), and bone morphogenetic proteins (BMPs)), PTH, selective prostaglandin agonists, statins, and beta blockers.”

    From Methods to accelerate fracture healing – a narrative review from a clinical perspective (2024) · cites this paper as [84]

    The growth-factors section (p. 3) reports benefits for FGF-2 and GH in animal studies, but does not identify FGF-1 as improving fracture repair; it discusses TGF-β in combination with IGF-1 rather than as a demonstrated benefit on its own. The Conclusion (p. 6) supports BMPs, PTH and selective prostaglandin agonists. The statins and beta-blockers section (p. 5) reports limited positive animal findings while emphasizing inconsistent or failed results, so the unqualified list overstates the review. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 4

  1. Kock H J, Werther S, Uhlenkott H, Taeger G. Influence of unfractionated and low-molecular-weight heparin on bone healing: an animal model. Unfallchirurg 2002; 105 (9): 791-6.
  2. Levander G. A study on bone regeneration. Surg Gynecol Obstetrics 1938; 67 (6): 705-14.
  3. O'Connor J P, Simon A M. Sustained inhibition of cox-2 decreases fracture healing success. J Bone Miner Res (Suppl 2) 2003; 18: 338.
  4. Persson P-E, Nilsson O S, Berggren A-M. Long-time outcome of total hip arthroplasty. Effects of non-steroidal anti-inflammatory drugs. Acta Orthop 2005; 76: 735-40.

Cited by

Sorted by citations

Authors
Aspenberg, P.
Affiliations
Linköping University (SE)
Corresponding author
Aspenberg, Per
Venue
Acta Orthopaedica
Published
2005-01
Volume
76
Issue
6
Pages
741-748
ISSN
  • 1745-3674 (ISSN-L)
  • 1745-3682
OpenAlex
W2094654701
Cited by
97
References
65
Citations by year
2025: 1 · 2024: 2 · 2023: 4 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 4 · 2018: 3 · 2017: 6 · 2016: 4 · 2015: 4 · 2014: 5 · 2013: 2 · 2012: 5
FWCI
1.21
Type
journal article
Language
en
Open access
Locations
  • Acta Orthopaedica (publishedVersion)
  • Acta Orthopaedica (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Bone fractures and treatments
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
Keywords
fracture healing, bone regeneration, long bones, drugs, osteoporosis
MeSH terms
Adrenal Cortex Hormones, Adrenergic beta-Antagonists, Animals, Anti-Bacterial Agents, Anticholesteremic Agents, Anticoagulants, Antineoplastic Agents, Fibrinolytic Agents, Growth Substances, Humans, Osteogenesis, Parathyroid Hormone, Receptors, Prostaglandin, Cyclooxygenase Inhibitors, Fracture Healing, Bone Morphogenetic Proteins, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review